Login to Your Account

Omeros Savors Sweet Success In Phase III Ophthalmology Trial

By Catherine Shaffer
Staff Writer

Wednesday, March 14, 2012
A Phase III trial of a product in development to prevent complications during delicate intraocular lens replacement surgery met its primary and secondary endpoints, Omeros Corp. reported Tuesday.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription